Frank Esper, MD, is a pediatric infectious disease specialist in the Division of Pediatric Infectious Disease and Rheumatology, University Hospitals Rainbow Babies & Children’s Hospital. He is Assistant Professor, Pediatrics, Case Western Reserve School of Medicine.
Dr. Esper is board certified in pediatrics and pediatric infectious diseases. His special interest is pediatric viral respiratory infections and emerging infectious diseases.
Dr. Esper earned his bachelor’s degree from Case Western Reserve University and his doctorate in medicine from Case Western Reserve University School of Medicine. He completed a residency in pediatrics at Riley Hospital for Children, Indianapolis, Ind., followed by a fellowship in pediatric infectious disease, Yale University, New Haven, Conn.
He has published more than 20 articles in peer-reviewed medical journals and coauthored three textbook chapters. He is a reviewer for several notable medical journals, including Pediatric Infectious Disease Journal, Journal of Infectious Diseases and Journal of the Pediatric Infectious Disease Society.
He is a member of the Pediatric Infectious Disease Society and the Infectious Disease Society of America.
American Board of Pediatrics - Pediatric Infectious Diseases
Education & Training
1992, Case Western Reserve University
Medical / Professional School(s)
1998, Case Western Reserve University School of Medicine
1999, Pediatrics - Riley Hospital for Children (James Whitcomb Riley Hospital for Children)
2001, Pediatrics - Riley Hospital for Children (James Whitcomb Riley Hospital for Children)
2005, Pediatric Infectious Diseases - Yale-New Haven Hospital
Viral Respiratory Diseases - Newly Discovered and Emerging
UH Rainbow Babies and Children's Hospital
Department of Pediatrics-Infectious Disease
11100 Euclid Ave
Rainbow Specialties Center
960 Clague Rd
UH Westlake Health Center, Bldg A, Ste 1600
5850 Landerbrook Dr
UH Landerbrook Health Center, Ste 220
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Frank Esper, MD did not disclose any Outside Relationships with Industry.